loadpatents
name:-0.013603925704956
name:-0.0044918060302734
name:-0.00045013427734375
MASHIMA; Yukihiko Patent Filings

MASHIMA; Yukihiko

Patent Applications and Registrations

Patent applications and USPTO patent grants for MASHIMA; Yukihiko.The latest application filed is for "method for treating geographic atrophy associated with age-related macular degeneration".

Company Profile
0.5.14
  • MASHIMA; Yukihiko - Tokyo JP
  • Mashima; Yukihiko - Chiyoda-ku JP
  • Mashima; Yukihiko - Tokyo-to JP
  • Mashima, Yukihiko - Nakano-ku Tokyo
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method For Treating Geographic Atrophy Associated With Age-related Macular Degeneration
App 20170042908 - SHIRAGA; Fumio ;   et al.
2017-02-16
Method for screening an agent being useful for the treatment of dry eye and/or corneal and conjunctival lesion and a pharmaceutical composition obtained by the method
Grant 9,205,154 - Mashima , et al. December 8, 2
2015-12-08
Method For Screening An Agent Being Useful For The Treatment Of Dry Eye And /or Corneal And Conjunctival Lesion And A Pharmaceutical Composition Obtained By The Method
App 20150011475 - MASHIMA; Yukihiko ;   et al.
2015-01-08
Method for screening an agent being useful for the treatment of dry eye and/or corneal and conjunctival lesion and pharmaceutical composition obtained by the method
Grant 8,871,995 - Mashima , et al. October 28, 2
2014-10-28
Pharmaceutical Composition For Inflammatory Diseases, Allergic Diseases And Autoimmune Diseases
App 20140212441 - Mashima; Yukihiko ;   et al.
2014-07-31
Aqueous Ophthalmic Composition
App 20120263803 - MASHIMA; Yukihiko ;   et al.
2012-10-18
Method For Screening An Agent Being Useful For The Treatment Of Dry Eye And / Or Corneal And Conjunctival Lesion And Pharmaceutical Composition Obtained By The Method
App 20120245090 - Mashima; Yukihiko ;   et al.
2012-09-27
Method for diagnosing or predicting susceptibility to optic neuropathy
Grant 8,182,990 - Mashima May 22, 2
2012-05-22
Method For Diagnosing And/or Evaluating Retinal Disease
App 20120087864 - MASHIMA; Yukihiko ;   et al.
2012-04-12
Method For Treating Retinal Disease
App 20110275715 - MASHIMA; Yukihiko ;   et al.
2011-11-10
Method For Treating Macular Edema
App 20110275711 - MASHIMA; Yukihiko ;   et al.
2011-11-10
Pharmaceutical Composition For The Treatment Of Dry Eye And/or Corneal And Conjunctival Lesion
App 20110065642 - Mashima; Yukihiko ;   et al.
2011-03-17
Pharmaceutical Composition For Treatment Of Cataract
App 20100210697 - Mashima; Yukihiko ;   et al.
2010-08-19
Composition For Ophtalmic Disease Associated With Hypoxia Or Ischemia
App 20100190834 - Mashima; Yukihiko ;   et al.
2010-07-29
Method for Diagnosing or Predicting Susceptibility to Optic Neuropathy
App 20080221050 - Mashima; Yukihiko
2008-09-11
Apoptosis inhibitor
Grant 7,129,272 - Ueno , et al. October 31, 2
2006-10-31
Apoptosis inhibitor
App 20020025985 - Ueno, Ryuji ;   et al.
2002-02-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed